Preclinical Development of KAN-001: Using Kanvas’ In-House Spatial Host-Microbiome Platform to Inform & Accelerate LBP Development
Time: 11:30 am
day: Conference Day Two
Details:
- KAN-001 is a complex LBP consortia candidate derived from a single cancer patient who had a complete response to ICI therapy
- The patient’s stool, through FMT, has converted multiple ICI-refractory patients to responders
- Kanvas’ spatial biology platform was used to accelerate strain isolation, visually measure engraftment and inform consortia member selection via microbe-microbe and host-microbe interactions
